These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30552397)

  • 1. Distinct patterns of transcriptional and epigenetic alterations characterize acute and chronic kidney injury.
    Sharifian R; Okamura DM; Denisenko O; Zager RA; Johnson A; Gharib SA; Bomsztyk K
    Sci Rep; 2018 Dec; 8(1):17870. PubMed ID: 30552397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia as a key player in the AKI-to-CKD transition.
    Tanaka S; Tanaka T; Nangaku M
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of epigenetic changes at ischemia/reperfusion- and endotoxin-induced acute kidney injury genes.
    Mar D; Gharib SA; Zager RA; Johnson A; Denisenko O; Bomsztyk K
    Kidney Int; 2015 Oct; 88(4):734-44. PubMed ID: 26061546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
    Li Z; Li N
    Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition.
    Ko GJ; Grigoryev DN; Linfert D; Jang HR; Watkins T; Cheadle C; Racusen L; Rabb H
    Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1472-83. PubMed ID: 20181666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
    Takaori K; Yanagita M
    Nephron; 2016; 134(3):172-176. PubMed ID: 27398799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.
    He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z
    Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.
    Ogbadu J; Singh G; Aggarwal D
    Eur J Pharmacol; 2019 Dec; 865():172711. PubMed ID: 31589870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rodent models of AKI-CKD transition.
    Fu Y; Tang C; Cai J; Chen G; Zhang D; Dong Z
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1098-F1106. PubMed ID: 29949392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
    Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
    Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
    Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
    Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
    Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of SIK1 in the transition of acute kidney injury into chronic kidney disease.
    Hu J; Qiao J; Yu Q; Liu B; Zhen J; Liu Y; Ma Q; Li Y; Wang Q; Wang C; Lv Z
    J Transl Med; 2021 Feb; 19(1):69. PubMed ID: 33588892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent effects of AKI to CKD models on inflammation and fibrosis.
    Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.
    Ó hAinmhire E; Humphreys BD
    Nephron; 2017; 137(4):264-267. PubMed ID: 28595180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of LncRNAs in AKI-to-CKD transition: A therapeutic and diagnostic viewpoint.
    Puri B; Majumder S; Gaikwad AB
    Life Sci; 2024 Apr; 342():122509. PubMed ID: 38387702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into acute kidney injury-chronic kidney disease continuum and the role of renin-angiotensin system.
    Chou YH; Huang TM; Chu TS
    J Formos Med Assoc; 2017 Sep; 116(9):652-659. PubMed ID: 28615146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.